- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroblastoma in New Zealand
Total 173 results
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Stage 4S Neuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States, Puerto Rico, Canada, Australia, New Zealand, Netherlands, Saudi Arabia, Switzerland
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastoma | High-risk Neuroblastoma | Metastatic NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
University of VirginiaNational Cancer Institute (NCI)UnknownRecurrent Neuroblastoma | Disseminated NeuroblastomaUnited States
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia
-
Clarity Pharmaceuticals LtdRecruitingNeuroblastoma | Refractory Neuroblastoma | Relapsed NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterNo longer available
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated NeuroblastomaUnited States, Canada
-
National Cancer Institute (NCI)United TherapeuticsCompletedRecurrent Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico
-
United TherapeuticsTerminatedPrimary Refractory NeuroblastomaUnited States
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteActive, not recruitingRelapsed NeuroblastomaUnited States
-
National Cancer Institute (NCI)CompletedHigh Risk NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent NeuroblastomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; Weill Medical College of Cornell... and other collaboratorsRecruitingNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterY-mAbs Therapeutics; Band of ParentsCompletedNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroblastomaUnited States
-
Columbia UniversityTerminatedNeuroblastomaUnited States
-
Northwell HealthCohen Children's Medical CenterAvailableNeuroblastoma | PheochromocytomaUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastoma | Pediatric CancerUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingMelanoma | Sarcoma | NeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroblastomaUnited States
-
GE HealthcareApproved for marketingNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingNeuroblastoma | High-RiskUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroblastoma | Bone Marrow, Sympathetic Nervous SystemUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States